Prevention of hepatitis B reactivation in patients with hematologic malignancies treated with novel systemic therapies: Who and Why?

Authors:
Tonnini M; Solera Horna C; Ielasi L.

Journal:
World J Gastroenterol

Publication Year: 2024

DOI:
10.3748/wjg.v30.i5.509

PMCID:
PMC10895601

PMID:
38414584

View on PubMed View on PMC View Publisher
Journal Information

Full Title: World J Gastroenterol

Abbreviation: World J Gastroenterol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Antiviral treatment standards for hepatitis B: An urgent need for expansion.
Bao ZH; Dai ZK; Tang HX. (2024) - Transparency Score: 2/6
Automatic detection of small bowel lesions with different bleeding risks based on deep learning mod…
Zhang RY; Qiang PP; Cai LJ and 5 more (2024) - Transparency Score: 3/6
Bile acids inhibit ferroptosis sensitivity through activating farnesoid X receptor in gastric cance…
Liu CX; Gao Y; Xu XF and 10 more (2024) - Transparency Score: 3/6
Cholecystokinin and cholecystokinin-A receptor: An attractive treatment strategy for biliary dyskin…
Chang J; Liu Y; Jiang TC and 2 more (2024) - Transparency Score: 2/6
Circulating microRNA expression and nonalcoholic fatty liver disease in adolescents with severe obe…
Li YJ; Baumert BO; Stratakis N and 20 more (2024) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025